US5179112A
(en)
*
|
1985-04-17 |
1993-01-12 |
Ici Americas Inc. |
Heterocyclic amide derivatives and pharmaceutical use
|
GB8623429D0
(en)
*
|
1985-10-17 |
1986-11-05 |
Ici America Inc |
Carboximide derivatives
|
IL80336A
(en)
*
|
1985-10-17 |
1990-02-09 |
Ici America Inc |
Indole or benzopyrazole derivatives,their preparation and pharmaceutical compositions containing them
|
ZA892643B
(en)
*
|
1988-04-14 |
1989-12-27 |
Ici America Inc |
Carbocyclic compounds
|
GB8911854D0
(en)
*
|
1989-05-23 |
1989-07-12 |
Ici Plc |
Heterocyclic compounds
|
US4965066A
(en)
*
|
1989-06-06 |
1990-10-23 |
E. I. Du Pont De Nemours And Company |
Intranasal administration of 3,3-disubstituted indolines
|
DK0455596T3
(da)
*
|
1990-05-04 |
1994-11-28 |
Ciba Geigy Ag |
Substituerede indoler
|
GB9026427D0
(en)
*
|
1990-12-05 |
1991-01-23 |
Ici Plc |
Chemical process
|
IL100091A
(en)
*
|
1990-12-12 |
1998-08-16 |
Zeneca Ltd |
Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
|
GB9027018D0
(en)
*
|
1990-12-12 |
1991-01-30 |
Ici Plc |
Heterocyclic compounds
|
DE69212058T2
(de)
*
|
1991-03-11 |
1997-01-09 |
Kyowa Hakko Kogyo Kk |
Indol-Derivate
|
DE4123341A1
(de)
*
|
1991-07-15 |
1993-01-21 |
Thomae Gmbh Dr K |
Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
IT1251144B
(it)
*
|
1991-07-30 |
1995-05-04 |
Boehringer Ingelheim Italia |
Derivati del benzimidazolone
|
US5334597A
(en)
*
|
1991-10-17 |
1994-08-02 |
Merck Frosst Canada, Inc. |
Indole carbamates as leukotriene antagonists
|
DE59202229D1
(de)
*
|
1991-10-25 |
1995-06-22 |
Ciba Geigy Ag |
Verfahren zur Herstellung substituierter Indole.
|
EP0539329A1
(de)
*
|
1991-10-25 |
1993-04-28 |
Ciba-Geigy Ag |
Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten
|
US5272169A
(en)
*
|
1992-03-27 |
1993-12-21 |
The Dupont Merck Pharmaceutical Company |
(N-benzyl) acetaldehyde bicyclic heterocycles useful as topical antiinflammatories
|
US5217983A
(en)
*
|
1992-03-27 |
1993-06-08 |
Du Pont Merck Pharmaceutical Company |
(N-benzyl) acetaldehyde bicyclic heterocycles useful as topical antiinflammatories
|
GB9207236D0
(en)
*
|
1992-04-02 |
1992-05-13 |
Grosvenor Power Services Ltd |
Treatment of liquids
|
US5280039A
(en)
*
|
1992-11-04 |
1994-01-18 |
Pfizer Inc. |
Bicyclic carbamates and methods of treating inflammatory diseases using the same
|
US5439929A
(en)
*
|
1994-03-01 |
1995-08-08 |
Pfizer Inc. |
Bicyclic carbamates, pharmaceutical compositions and use
|
GB9415997D0
(en)
*
|
1994-08-08 |
1994-09-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
EP0702004A2
(de)
*
|
1994-09-15 |
1996-03-20 |
Ciba-Geigy Ag |
2,9-Diamino- und 2-amino-8-carbamoyl-4-hydroxy-alkansäureamid-derivative
|
ES2108641B1
(es)
*
|
1995-07-31 |
1998-08-16 |
Menarini Lab |
Sulfonimidas quinolonicas con accion antagonista de los leucotrienos.
|
CZ248798A3
(cs)
*
|
1996-02-08 |
1999-01-13 |
Merck And Co., Inc. |
Farmaceutický prostředek
|
DE19610882A1
(de)
*
|
1996-03-20 |
1997-09-25 |
Dresden Arzneimittel |
Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
GB9723985D0
(en)
|
1997-11-14 |
1998-01-14 |
Zeneca Ltd |
Pharmaceutical compositions
|
GB9726735D0
(en)
*
|
1997-12-18 |
1998-02-18 |
Zeneca Ltd |
Pharmaceutical compositions
|
CA2317439A1
(en)
|
1998-01-14 |
1999-07-22 |
Wayne J. Brouillette |
Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
|
US6861448B2
(en)
*
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
US6673827B1
(en)
|
1999-06-29 |
2004-01-06 |
The Uab Research Foundation |
Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
|
US6916841B2
(en)
*
|
1998-02-25 |
2005-07-12 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
US6828344B1
(en)
|
1998-02-25 |
2004-12-07 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
US6500853B1
(en)
|
1998-02-28 |
2002-12-31 |
Genetics Institute, Llc |
Inhibitors of phospholipase enzymes
|
EE200000573A
(et)
|
1998-03-31 |
2002-04-15 |
The Institutes For Pharmaceutical Discovery, Llc |
Asendatud indoolalkaanhapped
|
DE19821002A1
(de)
*
|
1998-05-11 |
1999-11-18 |
Dresden Arzneimittel |
Neue 1,5- und 3-O-substituierte 1H-Indazole mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US6262066B1
(en)
|
1998-07-27 |
2001-07-17 |
Schering Corporation |
High affinity ligands for nociceptin receptor ORL-1
|
US6194432B1
(en)
*
|
1998-10-13 |
2001-02-27 |
Fred D. Sheftell |
Prevention and treatment of migraine, cluster and other recurrent headaches using leukotriene antagonist drugs
|
TNSN99224A1
(fr)
|
1998-12-01 |
2005-11-10 |
Inst For Pharm Discovery Inc |
Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
|
AU6315300A
(en)
*
|
1999-07-26 |
2001-02-13 |
Shionogi & Co., Ltd. |
Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same
|
IT1320162B1
(it)
|
2000-02-09 |
2003-11-18 |
Rotta Research Lab |
Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico.
|
IL140096A0
(en)
*
|
2000-12-05 |
2002-02-10 |
Internat Specialty Products Is |
Process for preparation of zafirlukast
|
US7183410B2
(en)
*
|
2001-08-02 |
2007-02-27 |
Bidachem S.P.A. |
Stable polymorph of flibanserin
|
US20030060475A1
(en)
*
|
2001-08-10 |
2003-03-27 |
Boehringer Ingelheim Pharma Kg |
Method of using flibanserin for neuroprotection
|
UA78974C2
(en)
|
2001-10-20 |
2007-05-10 |
Boehringer Ingelheim Pharma |
Use of flibanserin for treating disorders of sexual desire
|
US10675280B2
(en)
|
2001-10-20 |
2020-06-09 |
Sprout Pharmaceuticals, Inc. |
Treating sexual desire disorders with flibanserin
|
KR101004187B1
(ko)
*
|
2003-01-13 |
2010-12-24 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
1,2-디클로로에탄 프리 조니사미드 결정 및 고순도조니사미드 결정의 제조방법
|
US20090317476A1
(en)
*
|
2003-07-31 |
2009-12-24 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
|
US20050026882A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
|
AU2004268847A1
(en)
*
|
2003-08-29 |
2005-03-10 |
Ranbaxy Laboratories Limited |
Inhibitors of phosphodiesterase type-IV
|
GB0324763D0
(en)
*
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
US20050113410A1
(en)
*
|
2003-11-03 |
2005-05-26 |
Mark Tawa |
Pharmaceutical salts of zafirlukast
|
WO2005051931A2
(en)
*
|
2003-11-26 |
2005-06-09 |
Ranbaxy Laboratories Limited |
Phosphodiesterase inhibitors
|
KR20070014184A
(ko)
*
|
2004-04-22 |
2007-01-31 |
베링거 인겔하임 인터내셔날 게엠베하 |
성기능 장애 치료용 신규 약제학적 조성물 ⅱ
|
US20050239798A1
(en)
*
|
2004-04-22 |
2005-10-27 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Method for the treatment of premenstrual and other female sexual disorders
|
US20060025420A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Boehringer Ingelheimn International GmbH |
Pharmaceutical compositions for the treatment of female sexual disorders
|
WO2006024471A1
(en)
*
|
2004-09-03 |
2006-03-09 |
Boehringer Ingelheim International Gmbh |
Method for the treatment of attention deficit hyperactivity disorder
|
EP1817034A1
(en)
|
2004-10-25 |
2007-08-15 |
Schering Corporation |
M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
|
RU2416601C2
(ru)
*
|
2005-02-25 |
2011-04-20 |
Оно Фармасьютикал Ко., Лтд. |
Соединение индола и его применение
|
US20080254114A1
(en)
*
|
2005-03-03 |
2008-10-16 |
Elan Corporation Plc |
Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
|
WO2006096439A2
(en)
*
|
2005-03-04 |
2006-09-14 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
|
US20060199805A1
(en)
*
|
2005-03-04 |
2006-09-07 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
|
CA2599721A1
(en)
*
|
2005-03-04 |
2006-09-14 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment and/or prevention of depression
|
JP2008540356A
(ja)
*
|
2005-05-06 |
2008-11-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
薬物乱用の治療方法
|
WO2006125042A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Boehringer Ingelheim International Gmbh |
Method for the treatment of drug-induced sexual dysfunction
|
JP2008540672A
(ja)
*
|
2005-05-19 |
2008-11-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
病状に起因する性的機能不全の治療方法
|
WO2007011626A2
(en)
|
2005-07-14 |
2007-01-25 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
WO2007014929A1
(en)
|
2005-08-03 |
2007-02-08 |
Boehringer Ingelheim International Gmbh |
Use of flibanserin in the treatment of obesity
|
ES2246742B1
(es)
*
|
2005-09-06 |
2007-02-01 |
Prous Institute For Biomedical Research S.A. |
Uso de un derivado de imidazol.
|
US7915286B2
(en)
|
2005-09-16 |
2011-03-29 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
|
BRPI0617673C1
(pt)
*
|
2005-10-19 |
2012-05-22 |
Ranbaxy Lab Ltd |
composições de inibidores de fosfodiesterase do tipo iv
|
US20070123540A1
(en)
*
|
2005-10-29 |
2007-05-31 |
Angelo Ceci |
Sexual desire enhancing medicaments comprising benzimidazolone derivatives
|
WO2007048803A1
(en)
*
|
2005-10-29 |
2007-05-03 |
Boehringer Ingelheim International Gmbh |
Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
|
US20070105869A1
(en)
*
|
2005-11-08 |
2007-05-10 |
Stephane Pollentier |
Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
|
WO2007096694A1
(es)
*
|
2006-02-22 |
2007-08-30 |
Ramiro Vergara |
Asociacion de principios activos neuroactivadores
|
KR20090005371A
(ko)
*
|
2006-05-09 |
2009-01-13 |
베링거 인겔하임 인터내셔날 게엠베하 |
폐경후 성욕 장애의 치료를 위한 플리반세린의 용도
|
WO2008000760A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Boehringer Ingelheim International Gmbh |
Flibanserin for the treatment of urinary incontinence and related diseases
|
JP2009543839A
(ja)
*
|
2006-07-14 |
2009-12-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
女性の性的障害を治療するためのフリバンセリンの使用
|
CN101104601B
(zh)
*
|
2006-07-14 |
2011-01-26 |
海南盛科生命科学研究院 |
一种新的扎鲁司特重要中间体的制备方法
|
JP5270542B2
(ja)
|
2006-07-22 |
2013-08-21 |
オキサジェン リミテッド |
Crth2アンタゴニスト活性を有する化合物
|
CL2007002214A1
(es)
*
|
2006-08-14 |
2008-03-07 |
Boehringer Ingelheim Int |
Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
|
EP2054041A2
(en)
*
|
2006-08-14 |
2009-05-06 |
Boehringer Ingelheim International GmbH |
Formulations of flibanserin and method for manufacturing the same
|
CN101505736A
(zh)
*
|
2006-08-25 |
2009-08-12 |
贝林格尔.英格海姆国际有限公司 |
控制释放系统及其制造方法
|
US20100029728A1
(en)
*
|
2006-09-22 |
2010-02-04 |
Ranbaxy Laboratories Limited |
Phosphodiesterase inhibitors
|
AU2007298549A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Ranbaxy Laboratories Limited |
Inhibitors of phosphodiesterase type-IV
|
US20080207659A1
(en)
*
|
2007-02-15 |
2008-08-28 |
Asit Kumar Chakraborti |
Inhibitors of phosphodiesterase type 4
|
MX2009009793A
(es)
*
|
2007-03-14 |
2009-10-16 |
Ranbaxy Lab Ltd |
Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
|
EP2124943A1
(en)
*
|
2007-03-14 |
2009-12-02 |
Ranbaxy Laboratories Limited |
Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
|
EP2170825A2
(en)
*
|
2007-07-30 |
2010-04-07 |
Auspex Pharmaceuticals, Inc. |
Substituted indoles
|
PE20091188A1
(es)
|
2007-09-12 |
2009-08-31 |
Boehringer Ingelheim Int |
Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
|
US20090149662A1
(en)
*
|
2007-12-05 |
2009-06-11 |
Raghupathi Reddy Anumula |
Processes for preparing zafirlukast
|
BRPI0821647A2
(pt)
*
|
2007-12-21 |
2015-06-16 |
Schering Plough Healthcare |
Realce da fotosestabillização de oximetazolina
|
US7750027B2
(en)
|
2008-01-18 |
2010-07-06 |
Oxagen Limited |
Compounds having CRTH2 antagonist activity
|
DK2250161T3
(da)
|
2008-01-18 |
2014-01-27 |
Atopix Therapeutics Ltd |
Forbindelser med CRTH2-antagonistaktivitet
|
US20100022613A1
(en)
*
|
2008-01-22 |
2010-01-28 |
Oxagen Limited |
Compounds Having CRTH2 Antagonist Activity
|
WO2009093029A1
(en)
*
|
2008-01-22 |
2009-07-30 |
Oxagen Limited |
Compounds having crth2 antagonist activity
|
EP2111861A1
(en)
|
2008-04-21 |
2009-10-28 |
Ranbaxy Laboratories Limited |
Compositions of phosphodiesterase type IV inhibitors
|
US20110112134A1
(en)
*
|
2008-05-16 |
2011-05-12 |
Amira Pharmaceuticals, Inc. |
Tricyclic Antagonists of Prostaglandin D2 Receptors
|
EP2300425A4
(en)
*
|
2008-06-24 |
2012-03-21 |
Panmira Pharmaceuticals Llc |
PROSTAGLANDIN D2 RECEPTOR CYCLOALCANEÝBINDLUCK ANTAGONISTS
|
WO2010085820A2
(en)
*
|
2009-01-26 |
2010-07-29 |
Amira Pharmaceuticals, Inc. |
Tricyclic compounds as antagonists of prostaglandin d2 receptors
|
TW201111392A
(en)
|
2009-06-16 |
2011-04-01 |
Schering Corp |
Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
|
EP2651930B1
(en)
*
|
2010-12-16 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
Biarylamide inhibitors of leukotriene production
|
US9394315B2
(en)
|
2012-05-08 |
2016-07-19 |
Lycera Corporation |
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
|
US9657033B2
(en)
|
2012-05-08 |
2017-05-23 |
Lycera Corporation |
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease
|
WO2014012954A1
(en)
|
2012-07-18 |
2014-01-23 |
Takeda Gmbh |
Treatment of partly controlled or uncontrolled severe asthma
|
CN103396353B
(zh)
*
|
2013-08-23 |
2015-05-20 |
海南通用三洋药业有限公司 |
一种扎鲁司特无定型态及其制备方法
|
GB201322273D0
(en)
|
2013-12-17 |
2014-01-29 |
Atopix Therapeutics Ltd |
Process
|
US9809561B2
(en)
|
2013-12-20 |
2017-11-07 |
Merck Sharp & Dohme Corp. |
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
|
US9663502B2
(en)
*
|
2013-12-20 |
2017-05-30 |
Lycera Corporation |
2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease
|
WO2015110394A1
(en)
|
2014-01-22 |
2015-07-30 |
Takeda Gmbh |
Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier)
|
US10532088B2
(en)
|
2014-02-27 |
2020-01-14 |
Lycera Corporation |
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
|
GB201407820D0
(en)
|
2014-05-02 |
2014-06-18 |
Atopix Therapeutics Ltd |
Polymorphic form
|
GB201407807D0
(en)
|
2014-05-02 |
2014-06-18 |
Atopix Therapeutics Ltd |
Polymorphic form
|
US10189777B2
(en)
|
2014-05-05 |
2019-01-29 |
Lycera Corporation |
Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease
|
AU2015256190B2
(en)
|
2014-05-05 |
2019-08-15 |
Lycera Corporation |
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease
|
CA2975997A1
(en)
|
2015-02-11 |
2016-08-18 |
Merck Sharp & Dohme Corp. |
Substituted pyrazole compounds as rorgammat inhibitors and uses thereof
|
CA2982847A1
(en)
|
2015-05-05 |
2016-11-10 |
Lycera Corporation |
Dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of ror.gamma. and the treatment of disease
|
KR20180025894A
(ko)
|
2015-06-11 |
2018-03-09 |
라이세라 코퍼레이션 |
Rory의 작용제로서 사용하기 위한 아릴 디히드로-2h-벤조[b][1,4]옥사진 술폰아미드 및 관련 화합물 및 질환의 치료
|
JP2018531957A
(ja)
|
2015-10-27 |
2018-11-01 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
RORγT阻害薬としての置換二環式ピラゾール化合物及びその使用
|
MX2018005004A
(es)
|
2015-10-27 |
2018-09-12 |
Merck Sharp & Dohme |
Compuestos de indazol substituidos como inhibidores de rorgammat y sus usos.
|
EP3368535B1
(en)
|
2015-10-27 |
2020-12-02 |
Merck Sharp & Dohme Corp. |
Heteroaryl substituted benzoic acids as rorgammat inhibitors and uses thereof
|
EP3168570A1
(fr)
|
2015-11-10 |
2017-05-17 |
Primetals Technologies France SAS |
Méthode de mesure de planéité d'un produit métallique et dispositif associé
|
KR101713303B1
(ko)
*
|
2015-12-24 |
2017-03-07 |
강원대학교산학협력단 |
2h-인다졸 유도체의 제조방법
|
JP7272655B2
(ja)
|
2017-01-30 |
2023-05-12 |
ウェスタン ニュー イングランド ユニバーシティ |
チオールイソメラーゼ阻害剤およびその使用
|
US10752585B2
(en)
|
2017-12-28 |
2020-08-25 |
Council Of Scientific & Industrial Research |
Process for the preparation of Zafirlukast and analogs thereof
|
CN109438414B
(zh)
*
|
2018-10-24 |
2021-03-16 |
常州大学 |
一种制备苯并1,3-氧硫杂环己烷-4-酮的方法
|
CN110183371B
(zh)
*
|
2019-04-11 |
2022-06-14 |
南京医科大学 |
一种扎鲁司特中间体的制备工艺
|
US20220401411A1
(en)
|
2019-10-08 |
2022-12-22 |
Rigshospitalet |
Zafirlukast derivatives for use as contraceptive agents
|
EP4340828A1
(en)
|
2021-05-19 |
2024-03-27 |
Quercis Pharma AG |
Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis
|
WO2023214391A1
(en)
|
2022-05-06 |
2023-11-09 |
Quercis Pharma AG |
Method for treating cancers and neurological diseases using quercetin-containing compositions
|